Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Vigil Neuroscience, Inc.
Updated Jul 16, 2026
Bruhn Suzanne Louise has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | DFTX | Definium Therapeutics, Inc. | A — Grant or award | 4.7K | $0.00 | |
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2025-08-05 | VIGL | Vigil Neuroscience, Inc. | D — Derivative transaction | 5.0K | — |
Bruhn Suzanne Louise is a corporate insider — currently tracked as Insider of Definium Therapeutics, Inc. (DFTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bruhn Suzanne Louise profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.